VAERS Explorer
Back to explore

Report #2867313

Received Oct 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
CT
Recovered
Unknown
Vaccinated
Oct 13, 2025
Onset
Oct 13, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUBLOK)SANOFI PASTEURUNKU8440AAOT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

expired flublok was accidentally given, what should they do, with no reported adverse event; Initial information received on 13-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to this US-SA-2025SA306990 This case involves an unknown age female patient who received expired dose of influenza trivalent recombinant vaccine [Flublok] with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Oct-2025, the patient received an expired 0.5 ml dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection, lot U8440AA, expiry date:30-Apr-2025, strength: standard, frequency: once, via intramuscular route in the arm nos (not otherwise specified) for Influenza immunisation with no reported adverse event (expired product administered) (latency: same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA306990: